Whalegun
Home

Acadia Pharmaceuticals ACAD paid Tiber Creek Group $80K for lobbying in Q1 2026 · Health Issues

Trade details

Type
Lobbying report
Amount
$80,000
Quarter
Q1 2026
Stock
Acadia Pharmaceuticals ACAD
Client
Acadia Pharmaceuticals
Reported
26/04/18

Up 0.0% from last quarter

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Acadia Pharmaceuticals's other lobbying reports

Acadia Pharmaceuticals ACAD paid Tiber Creek Group $80K for lobbying in Q1 2026 · Health Issues | Whalegun